NCT04375436View on ClinicalTrials.gov

Safety and Tolerability of NTRX-07 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

May 15, 2020

Study Completion Date

June 30, 2020

Conditions
Pain, Neuropathic
Interventions
DRUG

NTRX-07-SDD

NTRX-07-SDD for oral administration

Trial Locations (1)

92780

Orange County Research Center, Tustin

Sponsors
All Listed Sponsors
collaborator

Integrium

INDUSTRY

collaborator

Orange County Research Center

OTHER

lead

NeuroTherapia, Inc.

INDUSTRY

NCT04375436 - Safety and Tolerability of NTRX-07 in Healthy Volunteers | Biotech Hunter | Biotech Hunter